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doi:10.1Objectives: Endothelial dysfunction occurs in hypoxia-related states such as ischemic heart disease or heart sur-
gery. Intermediate- and small-conductance calcium-activated potassium channels (IKCa and SKCa) are closely
related to endothelium-dependent hyperpolarizing factor–mediated endothelial function. However, the status
of these KCa under hypoxia is unknown. We investigated whether endothelial dysfunction under hypoxic state
is related to the alterations of IKCa and SKCa and whether use of IKCa/SKCa activator may protect endothelium
from hypoxia–reoxygenation injury.
Methods: Isometric tension measurement, patch-clamp technique, intracellular membrane potential recording,
and molecular methods were used to study porcine coronary arteries and endothelial cells.
Results: Hypoxia–reoxygenation (60–30 minutes) decreased endothelium-dependent hyperpolarizing factor–
mediated relaxation at normothermia in Krebs solution (43.3%  6.3% vs 82.3%  2.9%) and in St Thomas’
Hospital cardioplegic solution (28.9%  1.8% vs 78.1%  3.0%) (P< .001) as well as at hypothermia in St
Thomas’ Hospital solution (43.1%  2.6%, P< .001). Hypoxia–reoxygenation markedly reduced endothelial
IKCa (2.8  0.6 vs 6.9  0.6 pA/pF) and SKCa currents (1.5  0.3 vs 4.3  0.4 pA/pF) (P<.05) and downregu-
lated endothelial IKCa expression. IKCa/SKCa activator 1-ethyl-2-benzimidazolinone enhanced K
þ current in
endothelial cells that was blunted by hypoxia. Further, 1-ethyl-2-benzimidazolinone restored (P < .001)
endothelium-dependent hyperpolarizing factor–mediated relaxation with hyperpolarization recovered from
6.0  0.3 to 7.8  0.4 mV (P< .05).
Conclusions: In porcine coronary arteries, hypoxia markedly reduced endothelial Kþcurrents related to IKCa and
SKCa with downregulation of protein expression and endothelium-derived hyperpolarizing factor function. IKCa/
SKCa activator may preserve endothelium-dependent hyperpolarizing factor–mediated relaxation with enhance-
ment of Kþcurrent in endothelial cells and cellular membrane potential hyperpolarization in smooth muscle cells
and may become a new strategy to protect coronary endothelium in cardiac surgery or transplantation. (J Thorac
Cardiovasc Surg 2011;141:501-10)E
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The Journal of Thoracic and CaVascular endothelium releases nitric oxide (NO),1,2
prostacyclin (PGI2),
3 and endothelium-derived hyperpolariz-
ing factor (EDHF)4 to regulate blood flow. The EDHF-
mediated relaxation and the associated hyperpolarization
involve intermediate conductance calcium-activated Kþ chan-
nels (IKCa) and small conductance calcium-activated K
þchan-
nels (SKCa) in the endothelial cell.
5,6 In the vascular smooth
muscle, various ion channels such as Ba2þ-sensitive, inward
rectifier Kþ channels (Kir), Naþ-Kþ-adenosine triphosphatase,7
and large conductance calcium-activated Kþ channels (BKCa)
are involved.8 Intraluminal application of blockers of IKCa
and SKCa, charybdotoxin, and apamin blocked the EDHF-
mediated function,9 providing direct evidence for the involve-
ment of endothelial IKCa and SKCa in this mechanism.
Ischemia–reperfusion (I-R) or hypoxia–reoxygenation
(H-R) injury remains the major cause of cardiac dysfunction
in ischemic heart disease and heart surgery including heart
transplantation. I-R/H-R injury involves damage to myo-
cytes as well as the coronary circulation (the vascular
smooth muscle and the endothelium). Compared with
vascular smooth muscle, endothelium is more vulnerablerdiovascular Surgery c Volume 141, Number 2 501
Abbreviations and Acronyms
ANOVA ¼ analysis of variance
BKCa ¼ large conductance calcium-
activated Kþ channels
CI ¼ confidence interval
1-EBIO ¼ 1-ethyl-2-benzimidazolinone
EDHF ¼ endothelium-derived
hyperpolarizing factor
HBO ¼ oxyhemoglobin
H-R ¼ hypoxia–reoxygenation
IKCa ¼ intermediate conductance calcium-
activated Kþ channels
Indo ¼ indomethacin
I-R ¼ ischemia–reperfusion
KCa ¼ calcium-activated potassium
channels
Kir ¼ inward rectifier Kþ channels
L-NNA ¼ NG-nitro-L-arginine
NO ¼ nitric oxide
PGI2 ¼ prostacyclin
SKCa ¼ small conductance calcium-
activated Kþ channels
ST solution ¼ St Thomas Hospital cardioplegic
solution
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Sto I-R/H-R injury.10,11 Previous studies have demonstrated
that alteration of endothelial function under I-R/H-R is
related not only to NO and PGI2, but also to EDHF
mechanism.12-14 However, whether the change of EDHF-
mediated function under I-R/H-R is related to the changes
of endothelial IKCa or SKCa remains unexplored. We tested
the hypothesis that endothelial dysfunction owing to H-R is
related to the alterations of IKCa and SKCa.
Furthermore, the role of Ca2þ-activated Kþchannel (KCa) in
ischemic preconditioning,15 normal coronary arteriole,16 or
smooth muscle17 has been reported. In one of our recent stud-
ies that mimics the clinical setting of heart surgery, we18 ob-
served the alterations of electrophysiologic properties and
related function of smooth muscle KCa in coronary arteries ex-
posed to ischemia or hyperkalemia. However, with regard to
coronary endothelium, although it has been reported that car-
dioplegia may damage coronary endothelial function19-22 and
that microvascular dysfunction caused by cardioplegic arrest
is likely in part owing to impaired function of IKCa and SKCa
in the coronary microcirculation,23 the electrophysiologic
mechanisms responsible for endothelial IKCa and SKCa dys-
function in I-R or H-R states are still largely unclear.
Our previous studies further demonstrated that in both
large and microcoronary arteries, the impaired endothelial
function is mainly related to the EDHF pathway,24-26
whereas NO release is not affected by Kþ at the502 The Journal of Thoracic and Cardiovascular Surgconcentration of 20 mmol/L.27 Owing to the importance of
endothelial IKCa and SKCa in the EDHF-mediated function,
we therefore aimed to investigate whether endothelial dys-
function under hypoxic state is related to the alterations of
IKCa and SKCa and whether use of IKCa and SKCa activator
may protect porcine coronary endothelium from H-R injury.
From this study, we suggested that a new strategy28 targeting
on the endothelial IKCa and SKCa may be beneficial to the
protection of endothelial function during heart surgery or
transplantation.
METHODS
Patch-Clamp Study of Endothelial IKCa and SKCa
Currents
Isolation and culture of endothelial cells. Fresh porcine
hearts from the hog (either sex) weighing about 30 kg, col-
lected from a local slaughterhouse, were placed in a container
filled with cold (4C) Krebs solution and immediately trans-
ferred to the laboratory. In brief, porcine large coronary ar-
teries were dissected into 4 3 4-mm strips and treated
with 0.2% collagenase (type I; Sigma Chemical Company,
St Louis, Mo) in phosphate-buffered saline solution for
25 minutes at 37C. After the enzyme digestion, the suspen-
sion was centrifuged at 1600 rpm for 5 minutes. The cells
were resuspended in 5 mL culture medium containing
90% Roswell Park Memorial Institute medium and 10% fe-
tal bovine serum with 100 U/mL penicillin and 100 mg/mL
streptomycin. After a 1-hour incubation at 37C, the
medium was replaced once to remove unattached cells.
Attached endothelial cells were cultured in a humidified in-
cubator with 5% CO2 at 37
C. For maintaining electrophys-
iologic properties of isolated coronary endothelial cells, only
primary cells were used for experiments.
Patch-clamp recording of IKCa and SKCa currents. K
þ
currents in porcine primary endothelial cells were measured
at room temperature (20C–24C) by whole-cell patch-clamp
technique. Pharmacologic blockers, iberiotoxin for BKCa,
charybdotoxin for IKCa, and apamin for SKCa were used to
differentiate the role of BKCa, SKCa and IKCa.
29,30 The
effect of IKCa/SKCa activator 1-ethyl-2-benzimidazolinone
(1-EBIO) on the Kþcurrent was also examined.
Hypoxia exposure of endothelial cells. The primary cul-
ture of endothelial cells (seeded on glass coverslips) was
placed in our renovated plastic cover–sealed myograph
chamber filled with Krebs solution, and the solution was
continuously bubbled with 95% N2–5% CO2
12 PO2 change
was monitored by an Oxygen Meter (model 781; Strathkel-
vin Instrument, Glasgow, Scotland, United Kingdom). The
effectiveness of the device for hypoxia exposure has been
demonstrated in our previous studies. The hypoxia in these
experiments was attempted to approximate that in relaxation
studies (1 hour). Endothelial cells were exposed to hypoxia
before being transferred to the experimental chamber for
current recording.ery c February 2011
Yang et al Evolving Technology/Basic ScienceProtein Expression of Endothelial IKCa—Western
Blot Analysis
Endothelial cells from porcine coronary arteries were
scraped from the luminal surface by a clean scalpel blade.31
Whole cell proteins were extracted from endothelial cells
and separated by an 8% sodium dodecysulfate–polyacryl-
amide gel. Separated proteins were electro-transferred onto
a polyvinylidene difluoride membrane and probed with
rabbit-raised anti-KCa3.1 primary antibodies followed by
anti-rabbit immunoglobulin antibodies (Alomone, Jerusa-
lem, Israel). Immunostained protein bands were visualized
by using electrochemoluminescent analysis system.E
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Isometric force study. Isometric forces of coronary
microarteries (200–450 mm) were studied in a myograph.
The details of preparation, mounting, and normalization
of microarteries have been published in our previous
studies.12,27,32,33
Membrane potential measurement. The membrane po-
tential of a single smooth muscle cell was measured by an
intracellular microelectrode as previously described.25,33
Hypoxia. During experiments, the solution was aerated
with a gas mixture of 95% O2–5% CO2 (normoxia). Hyp-
oxic condition was induced by switching bubbling gas
from 95% O2–5% CO2 to 95% N2–5% CO2 (hypoxia,
PO2<5 mm Hg) in the plastic cover–sealed chamber. PO2
was measured by an Oxygen Meter. This method has been
demonstrated to be successful in our laboratory.12
EDHF-mediated relaxation and hyperpolarization of
the vascular smooth muscle. EDHF-mediated relaxation
and hyperpolarization were studied with the presence of in-
domethacin (Indo, 7 mmol/L), NG-nitro-L-arginine (L-NNA,
300 mmol/L), and oxyhemoglobin (HbO, 20 mmol/L), as
we33 demonstrated previously. In the relaxation studies,
cumulative concentration–relaxation curves to bradykinin
(106 logM) were established in U46619 (10 nmol/L)-
precontracted microarteries. In the hyperpolarization
studies, the cellular membrane potential in response to
bradykinin (0.1 mmol/L) was recorded.Experimental Protocols
Protocol I. Effect of H-R on endothelial IKCa and SKCa
currents—patch-clamp study. Coronary endothelial cells
were exposed to either normoxia or hypoxia before the
current recording. The whole-cell Kþ current was recorded
in both groups of cells with further application of iberio-
toxin, followed by charybdotoxin and then apamin.
Changes in the charybdotoxin-sensitive IKCa current and
apamin-sensitive SKCa current in the endothelial cells
were further compared between the normoxic group and
the hypoxic group. The doses of iberiotoxin (100 nmol/L),
charybdotoxin (100 nmol/L), and apamin (100 nmol/L)The Journal of Thoracic and Cawere chosen on the basis of previous patch-clamp studies
on KCa.
29,30 In another set of experiments, Kþ currents in
response to the challenge of 1-EBIO (600 mmol/L29,30)
were recorded in endothelial cells with or without
hypoxic exposure.
Protocol II. Effect of H-R on protein expression of
endothelial IKCa and the effect of 1-EBIO. Porcine coro-
nary arteries were allocated to either normoxic group or hyp-
oxic group with or without the presence of 1-EBIO before
scraping of the luminal surface for collection of endothelial
cells. In the hypoxic group, coronary arteries were placed in
our renovated plastic cover–sealed myograph chamber filled
with Krebs or Krebs containing 1-EBIO (600 mmol/L) and
the solution was continuously bubbled with 95% N2–5%
CO2 to allow PO2 to drop below 5 mm Hg, as described in
the ‘‘Methods’’ section. The endothelial cells were har-
vested after 1 hour of exposure to normoxia or hypoxia
with or without 1-EBIO and the protein expression of IKCa
was determined.
Protocol III. Effect of H-R on contractility and EDHF-
mediated relaxation. Effect of H-R on contractility. Two
rings from the same microartery were allocated into 2 groups
(n¼ 7 in each group). Both were incubated in Krebs solution
at 37C. One was set as the control without hypoxia. The
other was subjected to 60 minutes of hypoxia followed by
30 minutes of reoxygenation. Concentration–contraction
curves to U46619 (106.5 logM) were then established.
Effect of H-R on EDHF-mediated relaxation. In these
experiments, again, 2 rings from the same coronary micro-
artery were allocated into 2 groups (n ¼ 6 in each group).
Both were incubated in Krebs solution at 37C. One was
set as the control without hypoxia. The other was sub-
jected to 60 minutes of hypoxia followed by 30 minutes
of reoxygenation. The EDHF-mediated relaxation to bra-
dykinin (106 logM) was established in the U46619-
precontraction.
The relaxation study is only reliable when the contraction
is not significantly altered by a certain degree of H-R. The
design for the above contractility study is to explore whether
the contraction after 60 minutes of hypoxia and 30 minutes
of reoxygenation is suitable to be used as the precontraction
to test the effect of H-R on relaxation.
Protocol IV. Effect of IKCa/SKCa activator 1-EBIO on
EDHF-mediated relaxation reduced by H-R. Two rings
were allocated to 2 groups (n ¼ 6), incubated in Krebs
solution and normalized at 37C. Both were subjected to
60 minutes of hypoxia followed by 30 minutes of reoxyge-
nation. In the 2 groups, the H-R was induced in the myo-
graph with or without addition of 1-EBIO (600 mmol/L).
After H-R and washout, the EDHF-mediated concentra-
tion–relaxation curve was established in response to brady-
kinin (106 logM) in the presence of L-NNA, Indo, and
HbO.rdiovascular Surgery c Volume 141, Number 2 503
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of 1-EBIO (ethanol 30 mL) (n ¼ 6) were performed that
showed no effect of the solvent on the EDHF-mediated
relaxation.
Protocol V. Effect of H-R on EDHF-mediated hyperpo-
larization and the effect of 1-EBIO—single cell mem-
brane potential measurement. A ring of the coronary
microartery was mounted in the myograph and normalized
as described earlier. A conventional glass microelectrode
was inserted into a single smooth muscle cell from the
adventitial surface of the ring and the cellular membrane
potential was measured.
Group A: Control group (n ¼ 6). With the presence of
L-NNA, Indo, and HbO, the resting membrane potential
of the smooth muscle cell in the vessel was recorded. Brady-
kinin (0.1 mmol/L) was then added to induce hyperpolariza-
tion and the membrane potential was continuously
measured.
Group B: Effect of H-R on the EDHF-mediated hyperpolar-
ization (n¼ 6). After 60 minutes of hypoxia followed by 30
minutes of reoxygenation, with the presence of L-NNA,
Indo, and HbO, the resting membrane potential and
EDHF-mediated hyperpolarization induced by bradykinin
in the smooth muscle cell were recorded.
Group C: Effect of 1-EBIO on the EDHF-mediated hyperpo-
larization in response to H-R (n¼ 6). In these experiments,
during 60 minutes of hypoxia and 30 minutes of reoxygena-
tion, 1-EBIO (600 mmol/L) was added into Krebs solution.
In the presence of L-NNA, Indo, and HbO, the resting
membrane potential and EDHF-mediated hyperpolarization
induced by bradykinin in the smooth muscle cell were
recorded.
Protocol VI. Effect of 1-EBIO on EDHF-mediated relax-
ation in St Thomas’ Hospital cardioplegic solution (ST
solution) at different temperatures. Group A: At 37C
(n ¼ 6). Two rings were allocated to 2 groups, both incu-
bated in Krebs solution and normalized at 37C. The Krebs
solution in the myograph chamber was then changed to ST
solution. The rings were incubated in ST solution at 37C
and subjected to hypoxia for 60 minutes followed by 30
minutes of reoxygenation with or without the presence of
1-EBIO (600 mmol/L), respectively. After H-R, the
EDHF-mediated relaxation curve to bradykinin (106
logM) was established in the presence of L-NNA, Indo,
and HbO.
Group B: At 4C (n ¼ 6). The protocol of these experiments
was similar to that in the group A except that during H-R in ST
solution, the temperature was reduced to 4C. These experi-
ments were designed owing to our previous findings that the
effect of H-R and ST solution is temperature-dependent.12504 The Journal of Thoracic and Cardiovascular SurgStatistical Analysis
Data were expressed as mean  SEM and were analyzed
with paired, unpaired t test, or analysis of variance (1-way
ANOVA) followed by the Scheffe´ F test when appropriate.Chemicals
Chemicals included the following: bradykinin, iberio-
toxin, charybdotoxin, apamin, L-NNA, Indo, HbO (Sigma);
1-EBIO (Tocris Cookson Ltd, Bristol, United Kingdom),
and U46619 (Cayman Chemical, Ann Arbor, Mich). ST
solution was purchased from David Bull Laboratories,
Mulgrave, Victoria, Australia.RESULTS
Protocol I. Effect of H-R on Endothelial IKCa and
SKCa Currents
Hypoxic exposure markedly reduced whole-cell Kþ cur-
rent of endothelial cells (26.0  1.1 pA/pF to 17.6 
1.2 pA/pF, at 100 mV, P< .01, n ¼ 4 in each group in
this protocol). BKCa blocker iberiotoxin did not cause signif-
icant inhibition on endothelial Kþ current, whereas applica-
tion of IKCa blocker charybdotoxin markedly reduced the
current with further inhibition observed with apamin,
a SKCa blocker. The current sensitive to charybdotoxin or
apamin was more significant in the normoxic group than
that in the hypoxic group. Charybdotoxin-sensitive current
was reduced from 6.9  0.6 pA/pF to 2.8  0.6 pA/pF after
hypoxic exposure and apamin-sensitive current (4.3 
0.4 pA/pF) was decreased to 1.5  0.3 pA/pF (P< .01).
The activation of 1-EBIO on Kþcurrent was blunted by hyp-
oxic exposure (30.6  1.5 vs 44.0  2.8 pA/pF under nor-
moxia, P< .01); however, the inhibition of hypoxia on the
basal Kþ current (18.5  1.9 vs 27.8  1.3 pA/pF) was re-
covered by the application of 1-EBIO (30.6  1.5 pA/pF,
P> .05) (Figure 1).Protocol II. Effect of H-R on Protein Expression of
Endothelial IKCa and the Effect of 1-EBIO
The protein content of IKCa in porcine coronary endothe-
lial cells was markedly decreased after H-R exposure
(n ¼ 6 in each group). Although pretreatment with the
IKCa/SKCa activator 1-EBIO during hypoxia may recover
Kþ current in endothelial cells to the level seen under nor-
moxic condition, as shown in Figure 1, G to I, there was no
alteration at the protein level of the endothelial IKCa
(Figure 2).Protocol III. Effect of H-R on Contractility and
EDHF-Mediated Relaxation
Resting force. There were no significant differences among
the arteries incubated in Krebs, ST solution, or ST solution
containing 1-EBIO, either at 37C or at 4C, regarding the
resting force (P> .05).ery c February 2011
FIGURE 1. Representative traces (A) and current–voltage relationship of the whole-cell Kþcurrent of porcine coronary artery endothelial cells without (nor-
moxia, A and B) or with the exposure to hypoxia–reoxygenation (H/R) (C and D). Currents were elicited by 20 mV step pulses from100 toþ100 mV with
a holding potential of60 mV. BKCa blocker iberiotoxin (IbTX; 100 nmol/L) did not significantly inhibit the current, whereas further application of IKCa
blocker charybdotoxin (ChTX; 100 nmol/L) markedly reduced the current with further inhibition observed upon the application of SKCa blocker apamin
(Apa; 100 nmol/L). **P< .001, *P< .05 versus control; ##P< .01, #P< .05 versus IbTX and ChTX. Hypoxia reduced ChTX-sensitive (E) and apamin-
sensitive Kþcurrent (F) (n ¼ 4). **P< .01 versus normoxia. Activation of the whole-cell Kþcurrent by IKCa/SKCa activator 1-EBIO (600 mmol/L) (G, nor-
moxia) was blunted by hypoxic exposure (H); however, the inhibition of hypoxia on basal Kþcurrent was recovered by the application of 1-EBIO (I) (n¼ 4).
**P< .01 versus control (Con), ##P< .01 versus control or 1-EBIO in normoxia group. P> .05, 1-EBIO in hypoxia versus control in normoxia.
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FIGURE 1. (continued).
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SEffect of H-R on contractility. Hypoxia for 60 minutes,
followed by 30 minutes of reoxygenation, did not signifi-
cantly alter the contraction to U46619 (Figure 3, A) but
significantly reduced the EDHF-mediated relaxation
(Figure 3, B). These results indicate that contraction is
more tolerant to H-R than the endothelium-dependent relax-
ation (EDHF-mediated). Therefore, the EDHF-mediated re-
laxation in response to 60 minutes of hypoxia and 30 minutes
of reoxygenation was able to be tested in this project.
Effect of H-R on EDHF-mediated relaxation. Exposure
to hypoxia for 60 minutes in Krebs solution at 37C followed
by 30 minutes of reoxygenation significantly decreased
bradykinin-induced, EDHF-mediated relaxation from
82.3%  2.9% to 43.3%  6.3% (P< .001, 95% confi-
dence interval [CI]: 29.0%–47.7%) with unchanged EC50
(effective concentration to induce 50% of the maximum ef-
fect) (7.60  0.08 vs7.73  0.83 logM in the control
group, P ¼ .29, 95% CI:0.13 to 0.39 logM; Figure 3, B).Protocol IV. Effect of IKCa/SKCa Activator 1-EBIO
on EDHF-Mediated Relaxation Reduced by H-R
Addition of 1-EBIO to Krebs solution during 60 minutes
of hypoxia and 30 minutes of reoxygenation restored the506 The Journal of Thoracic and Cardiovascular SurgEDHF-mediated relaxation (90.7%  3.6%, compared
with 43.4%  5.8% without 1-EBIO, P< .001, 95% CI:
30.8%–61.8%; Figure 3, C). With regard to EC50, no signif-
icant change was observed (7.76  0.11 vs7.60  0.08
logM, P ¼ .26, 95% CI:0.14 to 0.46 logM).Protocol V. Effect of H-R on EDHF-Mediated
Hyperpolarization and the Effect of 1-EBIO—Single
Cell Membrane Potential Measurement
Exposure to H-R with or without 1-EBIO did not alter the
resting membrane potential of the porcine coronary smooth
muscle cell (control:57.2 1.0 mV; H-R:57.4 1.6 mV;
H-Rþ1-EBIO:59.6  0.5 mV, P ¼ .285 between groups,
P ¼ .99: control vs H-R; P ¼ .36: control vs H-Rþ1-
EBIO; P ¼ .41: H-R vs H-Rþ1-EBIO, 1-way ANOVA,
Figure 4, A). However, H-R significantly decreased the am-
plitude of the EDHF-mediated hyperpolarization to bradyki-
nin from 8.6  0.5 mV to 6.0  0.3 mV (P ¼ .003, 1-way
ANOVA, Figure 4, B). Addition of 1-EBIO significantly re-
covered the hyperpolarization (7.8  0.4 mV, P ¼ .47 vs
control, P ¼ .028 vs H-R, 1-way ANOVA, Figure 4, B).
Figure 4, C, gives examples of original traces of the cellular
membrane potential.ery c February 2011
FIGURE 2. IKCa protein expression in porcine coronary endothelial cells
exposed to 1 hour of normoxia (control), 1 hour of hypoxia (H/R), or 1 hour
of hypoxia with the presence of 1-EBIO (H/Rþ1-EBIO), followed by reox-
ygenation. Bar graphs show IKCa protein expression normalized to b-actin
(mean  SEM; n ¼ 6; **P< .01 vs control). IKCa, Intermediate conduc-
tance calcium-activated Kþ channels.
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Relaxation in ST Solution at Different Temperatures
Addition of 1-EBIO in ST solution significantly increased
the EDHF-mediated relaxation reduced by H-R in this solu-
tion (at 37C: 82.6%  2.6% vs 28.9%  1.8%, P<.001,
95% CI: 46.6%–60.7%, Figure 5, A; at 4C: 84.3% 
5.0% vs 43.1%  2.6%, P < .001, 95% CI:
28.7%–53.6%, Figure 5, B). Again, the change of EC50
did not reach statistical significance (7.69  0.11 vs
8.07  0.18 logM at 37C, P ¼ .11, 95% CI:0.10 to
0.85 logM and 7.46  0.08 vs 7.60  0.09 logM,
P ¼ .27, 95% CI:0.13 to 0.41 logM at 4C).10 9 8 7 6 
Bradykinin -LogM 
FIGURE 3. Effect of hypoxia (60 minutes) and reoxygenation (30 min-
utes) at 37C (H/R) on the contraction and EDHF-mediated relaxation in
porcine coronary microarteries (n ¼ 6 in each group). A, Concentration–
contraction curves to U46619. B, EDHF-mediated relaxation to bradykinin
in U46619 (10 nmol/L)-induced precontraction in the presence of indometh-
acin (7 mmol/L), NG-nitro-L-arginine (300 mmol/L), and oxyhemoglobin (20
mmol/L). Data are shown as mean SEM. *P<.05; **P<.001 compared
with control group (unpaired t test). C, EDHF-mediated concentration–
relaxation curves to bradykinin in U46619 (10 nmol/L)-precontracted micro-
arteries in the presence of indomethacin (7 mmol/L), NG-nitro-L-arginine
(300 mmol/L), and oxyhemoglobin (20 mmol/L) after hypoxia (60 min-
utes)–reoxygenation (30 minutes) at 37C in physiologic (Krebs) solution
with (H/R 1-EBIO) or without (H/R) addition of 1-EBIO (600 mmol/L) dur-
ing the H/R period. *P< .05; **P< .001, unpaired t test (n ¼ 6 in each
group). EDHF, Endothelium-derived hyperpolarizing factor.DISCUSSION
The present study for the first time demonstrated that in
porcine coronary arteries, (1) hypoxic exposure markedly
reduced endothelial IKCa and SKCa currents and protein con-
tent of IKCa with corresponding changes of EDHF-mediated
function; (2) the activator of IKCa/SKCa 1-EBIO may pre-
vent the reduction of the EDHF-mediated hyperpolarization
and associated relaxation caused by H-R and such effects are
in accordance with the enhancement of Kþcurrents in the en-
dothelial cells; (3) the protective effect of 1-EBIO also exists
when added in cardioplegic solutions. Therefore, addition of
the activator of IKCa/SKCa in cardioplegic solutions during
the H-R period may become a new strategy of protection
of coronary endothelium in cardiac surgery.The Journal of Thoracic and Cardiovascular Surgery c Volume 141, Number 2 507
FIGURE 4. Membrane potential measurement (n ¼ 6 in each group). A,
The resting membrane potential of smooth muscle cells of the porcine cor-
onary microartery under normalized condition without (control) or with
hypoxia (60 minutes)–reoxygenation (30 minutes) at 37C (H/R) or with
1-EBIO (600 mmol/L) during H/R (H/R[1-EBIO]). B, EDHF-mediated
hyperpolarization of a single smooth muscle cell of the coronary microartery
to bradykinin (0.1 mmol/L) in the presence of indomethacin (7 mmol/L),
NG-nitro-L-arginine (300 mmol/L), and oxyhemoglobin (20 mmol/L).
Data are shown as mean  SEM. **P < .01, H/R versus control;
#P< .05, H/R versus H/R (1-EBIO). No difference was observed between
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vasculature was well defined by others16,17,23,30 by using
multiple approaches such as patch-clamp, Western blotting,
immunohistochemistry, and gene expression. On the other
hand, the role and precise mechanisms of the endothelial
IKCa/SKCa and the activators of these channels on vascular
protection during ischemia/reperfusion are unclear at the
ion channel level. We therefore designed the present study
by using patch-clamp, molecular methods, as well as func-
tional investigations to reveal the mechanism.Hypoxic Exposure and KþCurrent of Endothelial
Cells
We have demonstrated that hypoxia markedly reduced
whole-cell Kþ current of endothelial cells and the reduction
mainly involves reduced currents of IKCa and SKCa. These
changes are coupled with the decreased protein level of
IKCa. Owing to the fact that SKCa has multiple subtypes
(SK1-3), we did not intend to identify the protein changes of
the subtypes of SKCa. Further, these changes are in accordance
with the functional test that showed reduced EDHF-mediated
relaxation, a widely known function of the endothelial IKCa
and SKCa.Activator of IKCa and SKCa and Endothelium
Kþ channels have particular importance in the endothe-
lium–smooth muscle interaction. First, a number of subtypes
of Kþ channels such as BKCa
8 and Kir as well as Naþ/Kþ
exchange pump7 located at the smooth muscle plasma
membrane are responsible for the smooth muscle hyperpo-
larization/relaxation in the EDHF pathway (Figure E1). Fur-
thermore, endothelial IKCa and SKCa are highly homologous
channels. Recent studies recruited IKCa as a member of SKCa
family and referred to it as SK4 owing to its high degree of
similarity with the other SKCa (SK1-SK3).
34
Activators of IKCa often activate SKCa as well. 1-EBIO
represents the first characterized pharmacologic opener of
IKCa
35 that also opens SKCa.
36 The role of IKCa and SKCa
in the EDHF pathway is probably related to the release of
EDHF from the endothelial cell. The known EDHFs such
as Kþ are released from the endothelial cell with activation
of IKCa and SKCa. Therefore, we hypothesized that previous
findings that the EDHF-mediated relaxation is reduced ow-
ing to H-R may be related to the alteration of the activity of
the endothelial IKCa and SKCa.control group and H/R (1-EBIO) group (P ¼ .47, 1-way ANOVA followed
by Scheffe´ F test). C, Original tracings of EDHF-mediated hyperpolariza-
tion induced by bradykinin. The arteries were under normalized condition
without (control) or with hypoxia (60 minutes)–reoxygenation (30 minutes)
at 37C (H/R) or with 1-EBIO (600 mmol/L) during H/R (H/R[1-EBIO]).
EDHF, Endothelium-derived hyperpolarizing factor; 1-EBIO, 1-ethyl-
2-benzimidazolinone.
:
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FIGURE 5. EDHF-mediated concentration-relaxation curves to brady-
kinin in U46619 (10 nmol/L)-precontracted microarteries in the presence
of indomethacin (7 mmol/L), NG-nitro-L-arginine (300 mmol/L), and oxyhe-
moglobin (20 mmol/L) after hypoxia (60 minutes)–reoxygenation (30 min-
utes) at 37C (A) or 4C (B) in St Thomas’ Hospital cardioplegic (ST)
solution with (H/R[ST,1-EBIO]) or without (H/R[ST]) addition of 1-EBIO
(600 mmol/L) during the H/R period. Data are shown as mean  SEM.
*P< .05, **P< .01, ***P< .001, unpaired t test (n ¼ 6 in each group).
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mine the mechanism underlying the reduction of the
EDHF-mediated relaxation. We conducted the present study
by directly measuring the single cell membrane potential in
association with relaxation studies under the condition that
the production of NO and PGI2 were abolished.
33 We are
therefore confident that the findings in the present study re-
garding hyperpolarization and relaxation are truly related to
EDHF—the ‘‘non-NO-non-PGI2’’ pathway. Importantly,
the role of IKCa and SKCa in this EDHF-mediated function
has been repeatedly demonstrated in our previous studiesThe Journal of Thoracic and Cain porcine coronary arteries33,37 as well as by others,38 indi-
cated by the potent inhibition of the specific inhibitors of
these channels—charybdotoxin and apamin.
The Effect of 1-EBIO in Physiologic andCardioplegic
Solution
In the present study, we demonstrated that addition of
1-EBIO may be favorable to the regulation of EDHF path-
way by maintaining the hyperpolarization in response to bra-
dykinin. This effect exists not only in physiologic solution
but also in ST solution. ST solution contains 20 mmol/L Kþ
that has been demonstrated to impair the EDHF-mediated
function.24-27 The hyperkalemia-induced inhibition of Kþ
channels is possibly decreased by addition of Kþ channel
openers. Use of activators of IKCa and SKCa is a new con-
cept, based on the fact that these two Kþchannels are directly
related to the mechanism of EDHF in the endothelial cell, as
mentioned earlier.
The present study was a continuous investigation to our
previous preliminary work.28 Owing to the difficulties in
the patch-clamp technique in the single porcine coronary en-
dothelial cell, we have not been able to complete this study
until recently.
Effect of Temperature
The present study also showed that the protective effect of
the activator of IKCa and SKCa exists under both normother-
mia and hypothermia. This is particularly important in car-
diac surgery when hypothermic cardioplegia is used to
protect the heart.
Clinical Implications
I-R/H-R injury is the major cause of mortality and morbid-
ity in cardiac surgery, including heart transplantation. Coro-
nary endothelial protection is an important aspect in
myocardial protection.21-28,39 In past decades, several
strategies have been developed to protect endothelium from
I-R/H-R injury.13 The present study specifically targets on
the IKCa and SKCa channels of the endothelial cell and dem-
onstrates the favorable effect of IKCa/SKCa activators in the
preservation of endothelial function during H-R. This study
provides evidence for a new strategy in the myocardial pro-
tection during cardiac surgery or in ischemic heart disease.
Limitation of Study
Although the clinical implications are clear, the present
study is an in vitro investigation in coronary arteries at the
level of single cell electrophysiology and vascular relaxa-
tion; to form a clinical protocol, more studies are warranted.
In conclusion, the present study demonstrated that in
porcine coronary arteries, hypoxia markedly reduced
endothelial Kþcurrents related to IKCa and SKCa with down-
regulation of protein expression and EDHF-mediated relax-
ation. We also demonstrated that addition of the activatorrdiovascular Surgery c Volume 141, Number 2 509
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may become a new strategy of protection of coronary endo-
thelium in cardiac surgery.References
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FIGURE E1. Schematic diagram describing the role of IKCa and SKCa in the EDHF pathway. In response to the agonist bradykinin, [Ca
2þ]i rises in endo-
thelial cells (EC) that leads to the release of NO, PGI2, and other substances that can hyperpolarize the endothelial as well as the smooth muscle cell (SMC)
such as Kþand epoxyeicosatrienoic acids (EETs)—so-called EDHFs. The opening of IKCa and SKCa of the EC leads to a number of physiologic consequences.
For example, Kþoutflows from these channels and stimulates the inward rectifier potassium channel (Kir) and NaþKþ-adenosine triphosphatase of the SMC7
to induce hyperpolarization of the SMC. On the other hand, other substances such as EETs may also open the endothelial IKCa and SKCa to induce hyper-
polarization of the EC.38 The endothelial hyperpolarization may electronically transfer to SMC through the myoendothelial gap junctions to lead hyperpo-
larization of the SMC. EETs also open the large conductance calcium-activated potassium channel (BKCa) of SMC that also hyperpolarizes the SMC.
38 The
hyperpolarization of SMC reduces the [Ca2þ]i and causes relaxation. IKCa, Intermediate conductance calcium-activated Kþchannels; SKCa, small conductance
calcium-activated Kþ channels; EDHF, endothelium-derived hyperpolarizing factor.
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